On this page, you will find an overview of medicines (temporarily) unavailable in Belgium that are relevant to a patient suffering from heart failure.
The table below also indicates the likely duration of unavailability and suggests possible alternatives.
This page is regularly updated, but may occasionally not be completely up to date.
The full list of medicines unavailable in Belgium can be consulted at the following address: FarmaStatus
Xarelto 10 mg, 15 mg and 20 mg are no longer reimbursed in Belgium since 01-09-2024.
Xarelto 2.5 mg will continue to be reimbursed as before.
Indefinite